Michael Rogers has served as a member of the board of directors since September 2020. Mr. Rogers currently serves as member of the Akebia Board of Directors and has served as Chairman of the Akebia Audit Committee since 2018. Previously, Mr. Rogers served as Chairman of the Board of Directors of Keryx and was a member of the Board of Directors of Keryx. He has held various executive leadership positions, including Chief Financial Officer of Aerpio Pharmaceuticals, Inc.; Chief Financial Officer of Acorda Therapeutics, Inc., a biotechnology company developing and commercializing therapies to treat neurological disorders; Chief Financial Officer of Indevus Pharmaceuticals, Inc. until the company’s sale to Endo Pharmaceuticals, Inc.; and Chief Financial Officer at BG Medicine, Inc., Advanced Health Corporation and Autoimmune Inc. Prior to his executive leadership roles, Mr. Rogers was an investment banker at Lehman Brothers and PaineWebber, where he focused on life sciences companies. He previously served on the Board of Directors for EyePoint Pharmaceuticals, formerly pSivida Corp. Mr. Rogers received his bachelors from Union College and earned his MBA from the Darden School of Business at the University of Virginia.